메뉴 건너뛰기




Volumn 30, Issue 2, 2010, Pages 200-202

Risperidone long-acting injectable in recent-onset schizophrenia examined with clinician and patient self-report measures

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR;

EID: 77952122994     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181d438e2     Document Type: Letter
Times cited : (14)

References (11)
  • 3
    • 41049103316 scopus 로고    scopus 로고
    • Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: A preliminary study
    • DOI 10.1097/JCP.0b013e318167269d, PII 0000471420080400000012
    • Emsley R, Medori R, Koen L, et al. Long-acting injectable risperidone in the treatment of subjects with recent-onset psychosis: a preliminary study. J Clin Psychopharmacol. 2008; 28:210-213. (Pubitemid 351419182)
    • (2008) Journal of Clinical Psychopharmacology , vol.28 , Issue.2 , pp. 210-213
    • Emsley, R.1    Medori, R.2    Koen, L.3    Oosthuizen, P.P.4    Niehaus, D.J.H.5    Rabinowitz, J.6
  • 5
    • 0032212679 scopus 로고    scopus 로고
    • Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project
    • DOI 10.1016/S0895-4356(98)00081-X, PII S089543569800081X
    • Ware JE Jr, Gandek B. Overview of the SF-36 Health Survey and the International Quality of Life Assessment (IQOLA) Project. J Clin Epidemiol. 1998; 51:903-912. (Pubitemid 28527145)
    • (1998) Journal of Clinical Epidemiology , vol.51 , Issue.11 , pp. 903-912
    • Ware Jr., J.E.1    Gandek, B.2
  • 6
    • 0025679231 scopus 로고
    • Positive-negative symptom assessment in schizophrenia: Psychometric issues and scale comparison
    • Kay SR. Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison. Psychiatr Q. 1990;61:163-178.
    • (1990) Psychiatr Q , vol.61 , pp. 163-178
    • Kay, S.R.1
  • 7
    • 0003412410 scopus 로고
    • Rev ed. Rockville, MD: National Institute of Mental Health, US Department of Health Education and Welfare
    • Guy W. ECDEU Assessment Manual for Psychopharmacology. Rev ed. Rockville, MD: National Institute of Mental Health, US Department of Health Education and Welfare; 1976.
    • (1976) ECDEU Assessment Manual for Psychopharmacology
    • Guy, W.1
  • 9
    • 0037012134 scopus 로고    scopus 로고
    • A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia
    • DOI 10.1056/NEJMoa002028
    • Csernansky JG, Mahmoud R, Brenner R. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia. N Engl J Med. 2002; 346:16-22. (Pubitemid 34438915)
    • (2002) New England Journal of Medicine , vol.346 , Issue.1 , pp. 16-22
    • Csernansky, J.G.1    Mahmoud, R.2    Brenner, R.3
  • 10
    • 14844334624 scopus 로고    scopus 로고
    • Remission in schizophrenia: Proposed criteria and rationale for consensus
    • Andreasen NC, Carpenter WT Jr, Kane JM, et al. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441-4449.
    • (2005) Am J Psychiatry. , vol.162 , pp. 441-4449
    • Andreasen, N.C.1    Carpenter Jr., W.T.2    Kane, J.M.3
  • 11
    • 68149132485 scopus 로고    scopus 로고
    • Dropout rates in antipsychotic controlled clinical trials: A meta-analysis comparing first and second generation drugs and examining trial design features
    • Rabinowitz J, Levine SZ, Barkai O, et al. Dropout rates in antipsychotic controlled clinical trials: a meta-analysis comparing first and second generation drugs and examining trial design features. Schizophr Bull. 2009; 35:775-788.
    • (2009) Schizophr Bull. , vol.35 , pp. 775-788
    • Rabinowitz, J.1    Levine, S.Z.2    Barkai, O.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.